Patent · US Active

Isocyanate and isothiocyanate compounds for cancer treatment

US8987316B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 18, 2012
Grant dateMar 24, 2015
Priority date
Expiry dateSep 18, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C331/28
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to novel isocyanate and isothiocyanate compounds, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans and animals. The novel isocyanate and isothiocyanate compounds are distinguished, as compared with the known isocyanate and isothiocyanate compounds, by improved therapeutical breadth, i.e. fewer side effects while having high anti-tumor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.